180 related articles for article (PubMed ID: 30039879)
1. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
[TBL] [Abstract][Full Text] [Related]
2. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
[TBL] [Abstract][Full Text] [Related]
3. How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.
Carney PA; Frederick PD; Reisch LM; Knezevich S; Piepkorn MW; Barnhill RL; Elder DE; Geller BM; Titus L; Weinstock MA; Nelson HD; Elmore JG
J Am Acad Dermatol; 2016 Feb; 74(2):317-24; quiz 324.e1-8. PubMed ID: 26559597
[TBL] [Abstract][Full Text] [Related]
4. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
[TBL] [Abstract][Full Text] [Related]
5. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
6. Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.
Castillo SA; Pham AK; Dagrosa AT; Yan S; Barton DT; Lefferts JA; Linos K
Am J Dermatopathol; 2020 Dec; 42(12):939-947. PubMed ID: 32675469
[TBL] [Abstract][Full Text] [Related]
7. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
8. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
Kiavash K; Bluth MH; Thompson AD
Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
[TBL] [Abstract][Full Text] [Related]
9. [Molecular diagnosis of melanocytic tumors].
Bauer J
Hautarzt; 2016 Jan; 67(1):59-63. PubMed ID: 26589514
[TBL] [Abstract][Full Text] [Related]
10. Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches.
March J; Hand M; Truong A; Grossman D
J Am Acad Dermatol; 2015 Jun; 72(6):943-58; quiz 959-60. PubMed ID: 25980999
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
12. Review of the current medical literature and assessment of current utilization patterns regarding human papillomavirus in situ hybridization and immunohistochemistry in dermatopathology.
Litzner BR; Lee JB; Vidal CI
J Cutan Pathol; 2017 Nov; 44(11):938-943. PubMed ID: 28796379
[TBL] [Abstract][Full Text] [Related]
13. Molecular Testing for Cutaneous Melanoma: An Update and Review.
Lee JJ; Lian CG
Arch Pathol Lab Med; 2019 Jul; 143(7):811-820. PubMed ID: 30354276
[TBL] [Abstract][Full Text] [Related]
14. Molecular testing practices and perceptions among dermatopathologists.
Torre K; Jhorar P; Wu R; Pfeifer J; Elaba Z; Murphy M
J Cutan Pathol; 2018 Jun; 45(6):387-394. PubMed ID: 29436726
[TBL] [Abstract][Full Text] [Related]
15. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
16. Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH.
Gerami P; Barnhill RL; Beilfuss BA; LeBoit P; Schneider P; Guitart J
Am J Surg Pathol; 2010 Jun; 34(6):816-21. PubMed ID: 20431478
[TBL] [Abstract][Full Text] [Related]
17. Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.
Miedema J; Andea AA
Mod Pathol; 2020 Jul; 33(7):1318-1330. PubMed ID: 32066861
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
19. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
Lang UE; Yeh I; McCalmont TH
Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
[TBL] [Abstract][Full Text] [Related]
20. Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation.
Mesbah Ardakani N; Thomas C; Robinson C; Mina K; Harvey NT; Amanuel B; Wood BA
Pathology; 2017 Apr; 49(3):285-291. PubMed ID: 28274670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]